Skip to main content
Top Button
Adam Sussman, Ph.D. is an attorney in Ice Miller’s Intellectual Property and Life Sciences Groups where he couples his technical background in synthetic organic chemistry with a passion for intellectual property law. Adam concentrates his practice on chemical, pharmaceutical, and biotechnological, patent prosecution and patent portfolio counseling. He works with clients on matters such as chemical compositions of matter, crystal forms, pharmaceutical formulations, dietary supplements, probiotics, methods of use of extracts, chemical product-by-process, medical devices, orthodontic systems, and more.

Adam provides insightful scientific analyses, skillfully articulated applications and determined advocacy before the USPTO and EPO so as to efficiently seek patent protection for his clients’ inventions. With years of experience in all phases of defensive Hatch-Waxman pharmaceutical patent litigation, Adam now works with clients to strategically minimize vulnerability of his clients’ patent claims to affirmative defenses in prospective enforcement and/or challenges in post-grant proceedings. His prosecution experience includes executing, analyzing and drafting client opinions on patentability and landscape searches, drafting and filing provisional and non-provisional (US & PCT) patent applications, preparing office action responses and helping to craft effective expert and inventor declarations. He has also corresponded with foreign agents on national stage prosecution of PCT patent applications and resolved outstanding objections and rejections through telephonic interviews with examiners.

Prior to practicing law, Adam was a chemistry instructor at Harold Washington College after earning his Doctor of Philosophy in chemistry with a focus in synthetic organic chemistry.

Adam and his wife, Karen, live with their French bulldog, Gambini, in the heart of the City of Chicago.
Representative Transactions
  • Achieved allowance of U.S. Patent Nos. 9,555,082; 9,675,585; 9,687,475; 9,718,947; 9,750,778; 9,883,924; 9,975,915; 10,000,520; 10,010,529; 10,010,571; 10,183,036
Selected Experience
  • Formulations and/or products litigated include Abilify, Botox, Byvalson, Gilenya, Levothyroxine sodium for injection, Nexium, OxyContin, Pradaxa, Restasis, and Treanda.
Published In
  • “A Real Separation of Powers or Separation of Law: Can an Article I Administrative Agency Nullify an Article III Federal Court Judgement?” Fordham Intellectual Property, Media and Entertainment Law Journal, 25, (2014). Co-author.
  • “Million-Card Monte: Reforming the Markush Claim Post-AIA to Save Synthetic Chemical Innovation,” J. Marshall Rev. Intell. Prop. L., 12(4), (2013).
  • “Intramolecular Oxamidation of Unsaturated O-Alkyl Hydroxamates: A Remarkably Versatile Entry to Hydroxy Lactams,” J. Am. Chem. Soc., 132, (2010). Co-author.
  • Doctoral Thesis: “Oxamidation & Bisamidation of I-Alkyl Hydroxamates & Studies Toward the Synthesis of Oseltamivir.”
View Full Site View Mobile Optimized